Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study


Creative Commons License

Aksu T., Guler T. E., ÇOLAK A., Baysal E., Durukan M., Sen T., ...More

BMC CARDIOVASCULAR DISORDERS, vol.15, 2015 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 15
  • Publication Date: 2015
  • Doi Number: 10.1186/s12872-015-0004-6
  • Journal Name: BMC CARDIOVASCULAR DISORDERS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: No-reflow, Epinephrine, Myocardial infarction, ACUTE MYOCARDIAL-INFARCTION, MICROVASCULAR OBSTRUCTION, REPERFUSION, TRIAL, ANGIOPLASTY, MECHANISMS, ABCIXIMAB, IMPROVES, THERAPY, FLOW
  • Dokuz Eylül University Affiliated: No

Abstract

Background: Despite the advances in medical and interventional treatment modalities, some patients develop epicardial coronary artery reperfusion but not myocardial reperfusion after primary percutaneous coronary intervention (PCI), known as no-reflow. The goal of this study was to evaluate the safety and efficacy of intracoronary epinephrine in reversing refractory no-reflow during primary PCI.